TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +44.40% | +41.97% | +52.27% | +57.38% | +59.85% |
| Gross Profit Growth | +37.09% | +39.85% | +45.86% | +52.25% | +62.43% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.14% | +22.31% | +37.63% | +62.47% | +76.76% |
| Weighted Average Shares Diluted Growth | +0.14% | +22.31% | +37.63% | +62.47% | +76.76% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +43.13% | +27.50% | +18.38% | +1.79% | +28.92% |
| Inventory Growth | +59.06% | +42.88% | +10.57% | -18.08% | -23.99% |
| Asset Growth | -2.55% | +60.01% | +27.40% | +32.70% | +47.39% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +1381.44% | +1994.62% | +47.88% | +45.52% | +45.76% |
| R&D Expense Growth | -61.26% | -43.73% | -15.92% | +22.68% | -13.15% |
| SG&A Expenses Growth | +0.41% | +3.46% | +28.71% | +24.23% | +4.10% |